My watch list
my.bionity.com  
Login  

511 Current news from france

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Merck acquires a French company

Merck Advances Bioprocessing Capabilities with Raman Technology Sensor Acquisition

02-Jul-2020

Merck enhanced its advanced bioprocess portfolio through the acquisition of RESOLUTION Spectra Systems, a Meylan, France-based leader in bioprocess analytical monitoring. The company offers Raman spectroscopy analysis through its GMP-ready instrumentation and software. Financial details of the ...

more

Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution

20-Apr-2020

Sanofi and Luminostics have signed an agreement to evaluate a collaboration on a unique self-testing solution for COVID-19, using Luminostics’ technology, and further adding to Sanofi’s ongoing efforts to fight the COVID-19 pandemic on multiple fronts.Luminostics would contribute its proprietary ...

more

image description
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

Companies have set up a Joint Task Force

15-Apr-2020

Sanofi and GSK announce that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic. Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA ...

more

image description
One Drug, Three Action Modes

Chemotherapy and photodynamic therapy combined in a single drug to fight resistant cancers

17-Mar-2020

Clinicians combat the drug resistances of some cancer types by using a combination of different drugs. To make this approach more effective, chemists have designed a chemical conjugate that can simultaneously attack several cellular targets using different modes of action. Such a single-drug ...

more

Bohui Innovation Biotechnology will acquire the Interchim group

27-Feb-2020

Advion Inc. announces parent company Beijing Bohui Innovation Biotechnology Co., Ltd., has filed its intention to acquire Adchim SAS, the parent company of the Interchim group companies. This transaction will subsequently result in the combination of Bohui’s subsidiary Advion Inc., a leader in ...

more

image description
€6 M to develop and launch a kit dedicated to sample preparation for single-cell RNA-sequencing

Paris-based biotechnology startup raises Series A financing

26-Feb-2020

Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces that it has secured a €6.0 M Series A financing from an international syndicate led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of ...

more

Domain Therapeutics is granted European and US patent for biosensors assessing GPCR trafficking

05-Feb-2020

Domain Therapeutics announced that it has been granted a patent in the US and in Europecovering a novel family of biosensors. The patent, entitled ‘Biosensors for monitoring biomolecule localization and trafficking in cells’, was initially filed by Prof. Michel Bouvier and his team and is part ...

more

image description
French biotech start-up raises €800k in seed funding

22-Jan-2020

Seekyo, a privately-owned biotech start-up specializing in the development of the next generation of chemotherapies,announces that it has completed a seed round of fundraising to the value of €800k ($889K). Thefunds will allow the company to accelerate the development of its flagship drug ...

more

Evotec expands service agreement with Sanofi to create a centralised global sample management hub in Toulouse

18-Dec-2019

Evotec SE announced plans to extend its sample management activities through an expansion of its service agreement with Sanofi. Evotec has had a successful track record of managing Sanofi’s powder compounds at its Toulouse site since 2015. Under the terms of the new agreement, Sanofi will ...

more

ImCheck Raises $53 Million Series B

05-Dec-2019

ImCheck Therapeutics, a biotech company developing a first-in-class antibody to activate gamma delta (γδ)T cells in a range of cancer indications and a portfolio of novel immunotherapies for the treatment of cancer and autoimmune diseases, announced the closing of a $53 million (€48 million) ...

more

Page 1 From 52
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE